Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis.

Soon Tjin LimVincent ThijsStephen J X MurphyIsrael Fernandez-CadenasJoan MontanerChika OffiahLars MarquardtPeter J KellyPhilip M BathSu-Yin LimGary A FordBo NorrvingDermot CoxCalin I ProdanPhilip A BarberDavid J WerringRichard PerryLina ZgagaJesse DawsonDominick J H McCabe

Published in: Journal of neurology (2020)

Antiplatelet-HTPR may predict risks of recurrent vascular events/outcomes in CVD patients. Given the heterogeneity between studies, further prospective, multi-centre studies are warranted.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
case control
metabolic syndrome
risk assessment
insulin resistance